Back
EHRA 2024 Premium Access

Safety and feasibility concerns of radiotherapy in the presence of subcutaneous implantable cardioverter-defibrillator

Session: Ventricular tachycardia 4
Topic: Radiotherapy
Speaker: Associate Professor M. Tajstra (Zabrze, PL)
Event: EHRA 2024

Congress Presentation

About the speaker

Associate Professor Mateusz Tajstra

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)
1 presentation
0 follower

8 more presentations in this session

Cryoablation of ventricular tachycardia using ultra-low temperature technology: acute success and insights from the post-interventional CMR

Speaker: Associate Professor B. Dinov (Giessen, DE)

Access
Abstract
Slides
Video
Thumbnail

Cardiac tumors with life threatening arrhythmia, an eight year single centre experience

Speaker: Doctor O. Kamel (Aswan, EG)

Access
Abstract
Slides
Video
Thumbnail

Coronary venous ethanol ablation of refractory left ventricular summit arrhythmias: comparison with radiofrequency ablation

Speaker: Doctor M. De Smet (Brugge, BE)

Access
Abstract
Slides
Video
Thumbnail

THerapy Efficacy in Short or long-coupled idiopathic ventricular fibrillation: an International Survey (THESIS)

Speaker: Doctor O. Tovia Brodie (Jerusalem, IL)

Access
Abstract
Slides
Video
Thumbnail

Initial experience with ablation of ventricular arrhythmias using a pulsed-field system

Speaker: Doctor P. Stojadinovic (Prague, CZ)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Ventricular tachycardia 4

Speakers: Associate Professor M. Tajstra, Associate Professor B. Dinov, Doctor O. Kamel, Doctor M. De Smet, Doctor O. Tovia Brodie...
Access
Thumbnail

About the event

Image

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb